Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for docetaxel-associated acute pain in breast cancer
ACTRN12611000666921Phase 3Terminated
- Sponsor
- Sunshine Coast Cancer Centre
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in acute pain (2 arms), sponsored by Sunshine Coast Cancer Centre. Primary endpoint: Worst new pain score. Started Jan 2012; status: terminated.
02
Drugs
gabapentin
03
Conditions
acute pain
Beyond the preview
Go deeper on ACTRN12611000666921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000666921.